<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">21491</article-id><article-id pub-id-type="doi">10.7554/eLife.21491</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>SPRTN is a mammalian DNA-binding metalloprotease that resolves DNA-protein crosslinks</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-2307"><name><surname>Lopez-Mosqueda</surname><given-names>Jaime</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0301-1971</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-68584"><name><surname>Maddi</surname><given-names>Karthik</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-68592"><name><surname>Prgomet</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-68593"><name><surname>Kalayil</surname><given-names>Sissy</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2309"><name><surname>Marinovic-Terzic</surname><given-names>Ivana</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2189"><name><surname>Terzic</surname><given-names>Janos</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1078"><name><surname>Dikic</surname><given-names>Ivan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8156-9511</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Institute of Biochemistry II</institution>, <institution>Goethe University School of Medicine</institution>, <addr-line><named-content content-type="city">Frankfurt am Main</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution content-type="dept">Department of Immunology and Medical Genetics, School of Medicine</institution>, <institution>University of Split</institution>, <addr-line><named-content content-type="city">Split</named-content></addr-line>, <country>Croatia</country></aff><aff id="aff3"><institution content-type="dept">Department of Immunology an Medical Genetics, School of Medicine</institution>, <institution>University of Split</institution>, <addr-line><named-content content-type="city">Split</named-content></addr-line>, <country>Croatia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-4003"><name><surname>Harper</surname><given-names>Wade</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>dikic@biochem2.uni-frankfurt.de</email> (ID);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>11</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e21491</elocation-id><history><date date-type="received"><day>14</day><month>09</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, Lopez-Mosqueda et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Lopez-Mosqueda et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-21491-v1.pdf"/><abstract><p>Ruijs-Aalfs syndrome is a segmental progeroid syndrome resulting from mutations in the SPRTN gene. Cells derived from patients with <italic>SPRTN</italic> mutations elicit genomic instability and persons afflicted with this syndrome developed hepatocellular carcinoma. Here we describe the molecular mechanism by which SPRTN contributes to genome stability and normal cellular homeostasis. We show that SPRTN is a DNA-dependent mammalian protease required for resolving cytotoxic DNA-protein crosslinks (DPCs); a function that had only been attributed to the metalloprotease Wss1 in budding yeast. We provide genetic evidence that SPRTN and Wss1 function distinctly <italic>in vivo</italic> to resolve DPCs. Upon DNA or ubiquitin binding, SPRTN can elicit proteolytic activity; cleaving DPC substrates or itself. <italic>SPRTN</italic> null cells or cells derived from patients with Ruijs-Aalfs syndrome are impaired in the resolution of covalent DPCs <italic>in vivo</italic>. Collectively, SPRTN is a mammalian protease required for resolving DNA-protein crosslinks <italic>in vivo</italic> whose function is compromised in Ruijs-Aalfs syndrome patients.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>E. coli</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB1177</award-id><principal-award-recipient><name><surname>Dikic</surname><given-names>Ivan</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>CEF-MC</award-id><principal-award-recipient><name><surname>Dikic</surname><given-names>Ivan</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000854</institution-id><institution>Human Frontier Science Program</institution></institution-wrap></funding-source><award-id>Postdoctoral fellowship</award-id><principal-award-recipient><name><surname>Lopez-Mosqueda</surname><given-names>Jaime</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>LOEWE Zentrum CGT and Loewe Network Ub Net</institution></institution-wrap></funding-source><award-id>Fellowships</award-id><principal-award-recipient><name><surname>Dikic</surname><given-names>Ivan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Ivan Dikic, Senior editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-21491-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>